Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IAPP | P10997 | 5/20 | 0.74 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.45 |
| ▸ | MPO | P05164 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11751573 | 0.88 | IAPP (0.59) | IAPPHTR1ATAAR1AKR1B1NPC1 | |
| SCHEMBL8005173 | 0.87 | IAPP (0.75) | IAPPHTR1ATAAR1AKR1B1NPC1 | |
| SCHEMBL27564988 | 0.82 | IAPP (0.55) | IAPPHTR1ATAAR1AKR1B1HSPA5 | |
| SCHEMBL8597351 | 0.81 | IAPP (0.59) | IAPPTAAR1NPC1RAB9ACYP4F2 | |
| SCHEMBL14935427 | 0.81 | IAPP (0.59) | IAPPTAAR1NPC1RAB9ACYP4F2 | |
| SCHEMBL30610413 | 0.80 | AKR1B1 (0.63) | IAPPHTR1ATAAR1AKR1B1HSPA5 | |
| SCHEMBL156141 | 0.80 | AKR1B1 (0.63) | IAPPHTR1ATAAR1AKR1B1HSPA5 | |
| SCHEMBL269353 | 0.80 | IAPP (0.72) | IAPPHTR1ATAAR1AKR1B1NPC1 | |
| SCHEMBL29934495 | 0.80 | IAPP (0.72) | IAPPHTR1ATAAR1AKR1B1NPC1 | |
| Butane SCHEMBL28254816 | 0.79 | AKR1B1 (0.57) | IAPPHTR1ATAAR1AKR1B1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117264697-A | Extraction of polyunsaturated fatty acid from marine microalgae | 裘海红 | 2023-12-22 | — | — | CN | disclosed |
| CN-115894515-A | Method for integrated extraction, enrichment, separation and purification of effective components of ginkgo leaves in full industrial chain | 李玉山 | 2023-04-04 | — | — | CN | disclosed |
| US-20150266810-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | V-BAC HOLDING CORP. (CA) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266810-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | TRPC4, TRPC3, TRPC1 | IAPP 814/4885HTR1A 234/4885TAAR1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.